No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4q1lA_, 1.0000, 0.00, 1.000, 202, 202, CRYSTAL STRUCTURE OF LEUCUROLYSIN-A COMPLEXED WITH AN ENDOGENOUS TRIPEPTIDE (QSW).
2, d3gboA_, 0.9838, 0.00, 1.000, 202, 202, CRYSTAL STRUCTURE OF BMOOMPALPHA-I A NON-HEMORRHAGIC METALLOPROTEINASE ISOLATED FROM BOTHROPS MOOJENI SNAKE VENOM
3, d1nd1A_, 0.9709, 0.43, 0.820, 200, 200, AMINO ACID SEQUENCE AND CRYSTAL STRUCTURE OF BAP1 A METALLOPROTEINASE FROM BOTHROPS ASPER SNAKE VENOM THAT EXERTS MULTIPLE TISSUE-DAMAGING ACTIVITIES.
4, d2w14A_, 0.9689, 0.98, 0.790, 201, 200, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
5, d2w12A_, 0.9689, 0.97, 0.790, 201, 200, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
6, d2w15A_, 0.9687, 0.97, 0.790, 201, 200, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
7, d2w13A_, 0.9676, 0.98, 0.790, 201, 200, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
8, d3aigA_, 0.9640, 1.00, 0.790, 201, 200, ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL656
9, d2aigP_, 0.9637, 1.23, 0.582, 201, 201, ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL647
10, d1iagA_, 0.9634, 1.23, 0.582, 201, 201, FIRST STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE: A PROTOTYPE FOR MATRIX METALLOPROTEINASES(SLASH)COLLAGENASES
11, d4aigA_, 0.9633, 1.24, 0.577, 201, 201, ADAMALYSIN II WITH PHOSPHONATE INHIBITOR
12, d1dthB_, 0.9627, 1.23, 0.582, 201, 201, METALLOPROTEASE
13, d1dthA_, 0.9624, 1.34, 0.584, 202, 202, METALLOPROTEASE
14, d1kugA_, 0.9608, 1.39, 0.584, 202, 202, CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH ITS ENDOGENOUS INHIBITOR PENW
15, d1kukA_, 0.9601, 1.04, 0.555, 201, 200, CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEKW.
16, d1kuiA_, 0.9601, 1.04, 0.555, 201, 200, CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEQW.
17, d1kufA_, 0.9593, 1.04, 0.555, 201, 200, HIGH-RESOLUTION CRYSTAL STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE FROM TAIWAN HABU
18, d1atlB_, 0.9591, 1.07, 0.555, 201, 200, STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE ATROLYSIN C (FORM-D)
19, d1atlA_, 0.9586, 1.24, 0.585, 200, 200, STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE ATROLYSIN C (FORM-D)
20, p3hdbA1, 0.9585, 1.24, 0.585, 200, 200, CRYSTAL STRUCTURE OF AAHIV A METALLOPROTEINASE FROM VENOM OF AGKISTRODON ACUTUS
21, p3dslA1, 0.9585, 1.36, 0.413, 209, 201, THE THREE-DIMENSIONAL STRUCTURE OF BOTHROPASIN THE MAIN HEMORRHAGIC FACTOR FROM BOTHROPS JARARACA VENOM.
22, p2erpA1, 0.9582, 1.13, 0.495, 211, 200, CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN-1(INHIBITOR- BOUND FORM)
23, p2erqB1, 0.9580, 1.25, 0.453, 219, 201, CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN-1(TETRAGONAL CRYSTAL FORM)
24, d1htdA_, 0.9578, 1.26, 0.453, 217, 201, STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE ATROLYSIN C (HT-D)
25, d1htdB_, 0.9577, 1.25, 0.585, 200, 200, STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE ATROLYSIN C (HT-D)
26, p2dw1B1, 0.9567, 1.26, 0.585, 200, 200, CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-2 CRYSTAL)
27, p2dw2B1, 0.9564, 1.10, 0.457, 207, 199, CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)
28, p2dw2A1, 0.9563, 1.07, 0.457, 207, 199, CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)
29, p2dw1A1, 0.9563, 1.08, 0.457, 207, 199, CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-2 CRYSTAL)
30, p2erpB1, 0.9561, 1.13, 0.457, 207, 199, CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN-1(INHIBITOR- BOUND FORM)
31, p2dw0A1, 0.9561, 1.27, 0.453, 219, 201, CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-1 CRYSTAL)
32, p2eroB1, 0.9551, 0.91, 0.460, 206, 198, CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN- 1(ORTHORHOMBIC CRYSTAL FORM)
33, p3k7nA1, 0.9545, 1.30, 0.453, 219, 201, STRUCTURES OF TWO ELAPID SNAKE VENOM METALLOPROTEASES WITH DISTINCT ACTIVITIES HIGHLIGHT THE DISULFIDE PATTERNS IN THE D DOMAIN OF ADAMALYSIN FAMILY PROTEINS
34, p2eroA1, 0.9543, 1.36, 0.453, 211, 201, CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN- 1(ORTHORHOMBIC CRYSTAL FORM)
35, p2dw0B1, 0.9540, 1.36, 0.453, 211, 201, CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-1 CRYSTAL)
36, p2erqA1, 0.9539, 1.30, 0.453, 219, 201, CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN-1(TETRAGONAL CRYSTAL FORM)
37, p3dslB1, 0.9535, 1.30, 0.453, 219, 201, THE THREE-DIMENSIONAL STRUCTURE OF BOTHROPASIN THE MAIN HEMORRHAGIC FACTOR FROM BOTHROPS JARARACA VENOM.
38, p2e3xA1, 0.9514, 0.96, 0.460, 206, 198, CRYSTAL STRUCTURE OF RUSSELL S VIPER VENOM METALLOPROTEINASE
39, d1yp1A_, 0.9494, 1.29, 0.453, 219, 201, CRYSTAL STRUCTURE OF A NON-HEMORRHAGIC FIBRIN(OGEN)OLYTIC METALLOPROTEINASE FROM VENOM OF AGKISTRODON ACUTUS
40, d4j4mB_, 0.9488, 1.21, 0.495, 210, 200, CRYSTAL STRUCTURE OF TM-1 A TRIMERESURUS MUCROSQUAMATUS VENOM METALLOPROTEINASE
41, d1wniA_, 0.9484, 1.10, 0.457, 207, 199, CRYSTAL STRUCTURE OF H2-PROTEINASE
42, d1quaA_, 0.9421, 1.10, 0.457, 207, 199, CRYSTAL STRUCTURE OF ACUTOLYSIN-C A HEMORRHAGIC TOXIN FROM THE SNAKE VENOM OF AGKISTRODON ACUTUS AT 2.2 A RESOLUTION
43, d1bswA_, 0.9375, 1.10, 0.379, 199, 198, ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 7.5
44, d4j4mA_, 0.9356, 1.10, 0.379, 199, 198, CRYSTAL STRUCTURE OF TM-1 A TRIMERESURUS MUCROSQUAMATUS VENOM METALLOPROTEINASE
45, d1budA_, 0.9356, 1.23, 0.523, 200, 199, ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 5.0
46, d1r54A_, 0.9325, 1.02, 0.543, 198, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM33
47, d1r55A1, 0.9286, 1.14, 0.487, 197, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM 33
48, d4dd8D_, 0.9227, 1.16, 0.518, 197, 197, ADAM-8 METALLOPROTEINASE DOMAIN WITH BOUND BATIMASTAT
49, d4dd8B_, 0.9197, 1.07, 0.523, 195, 195, ADAM-8 METALLOPROTEINASE DOMAIN WITH BOUND BATIMASTAT
50, d4dd8C_, 0.9130, 1.19, 0.518, 197, 197, ADAM-8 METALLOPROTEINASE DOMAIN WITH BOUND BATIMASTAT
51, d4dd8A_, 0.9117, 1.52, 0.363, 206, 201, ADAM-8 METALLOPROTEINASE DOMAIN WITH BOUND BATIMASTAT
52, p5y2zK1, 0.9033, 1.52, 0.363, 206, 201, CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP AND HUMAN ADAM22 COMPLEX 
53, p3g5cB1, 0.9030, 1.34, 0.369, 202, 198, STRUCTURAL AND BIOCHEMICAL STUDIES ON THE ECTODOMAIN OF HUMAN ADAM22
54, p3g5cA1, 0.9030, 1.59, 0.387, 208, 199, STRUCTURAL AND BIOCHEMICAL STUDIES ON THE ECTODOMAIN OF HUMAN ADAM22
55, p5y2zA1, 0.9026, 1.59, 0.387, 208, 199, CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP AND HUMAN ADAM22 COMPLEX 
56, p5y31C1, 0.9024, 1.57, 0.389, 205, 198, CRYSTAL STRUCTURE OF HUMAN LGI1 AND HUMAN ADAM22 COMPLEX 
57, p5y31A1, 0.9024, 1.42, 0.390, 201, 195, CRYSTAL STRUCTURE OF HUMAN LGI1 AND HUMAN ADAM22 COMPLEX 
58, p5y2zI1, 0.9023, 1.36, 0.392, 201, 194, CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP AND HUMAN ADAM22 COMPLEX 
59, p3k7lA2, 0.8710, 1.79, 0.264, 206, 197, STRUCTURES OF TWO ELAPID SNAKE VENOM METALLOPROTEASES WITH DISTINCT ACTIVITIES HIGHLIGHT THE DISULFIDE PATTERNS IN THE D DOMAIN OF ADAMALYSIN FAMILY PROTEINS
60, d3hy9B1, 0.8692, 1.74, 0.269, 206, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
61, d3hy7A_, 0.8687, 1.74, 0.269, 206, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH MARIMASTAT
62, p2rjqA1, 0.8683, 1.74, 0.269, 206, 197, CRYSTAL STRUCTURE OF ADAMTS5 WITH INHIBITOR BOUND
63, d3b8zB_, 0.8679, 1.80, 0.264, 206, 197, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 (AGGRECANASE-2)
64, d3hygB_, 0.8678, 1.80, 0.264, 206, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
65, d3hy9A_, 0.8678, 1.80, 0.264, 206, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
66, d3hy7B_, 0.8672, 1.80, 0.264, 206, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH MARIMASTAT
67, d3hygA_, 0.8668, 1.20, 0.464, 193, 183, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
68, d3b8zA_, 0.8666, 2.18, 0.249, 219, 193, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 (AGGRECANASE-2)
69, p3b2zG1, 0.8658, 1.96, 0.262, 217, 191, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
70, p3b2zC1, 0.8643, 1.90, 0.251, 220, 191, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
71, d3l0vA_, 0.8642, 1.90, 0.251, 220, 191, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THE FIRST HYDANTOIN INHIBITOR OCCUPYING THE S1  POCKET
72, d2oi0A2, 0.8632, 1.96, 0.251, 217, 191, CRYSTAL STRUCTURE ANALYSIS 0F THE TNF-A COVERTING ENZYME (TACE) IN COMPLEXED WITH ARYL-SULFONAMIDE
73, p3b2zF1, 0.8628, 1.98, 0.251, 217, 191, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
74, d1zxcB_, 0.8621, 1.96, 0.262, 217, 191, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) WITH INHIBITOR
75, d2fv5A1, 0.8617, 1.98, 0.257, 217, 191, CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH IK682
76, p3b2zA1, 0.8616, 1.98, 0.262, 217, 191, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
77, d3b92A_, 0.8613, 1.98, 0.262, 217, 191, NOVEL THIO-BASED TACE INHIBITORS PART 2: RATIONAL DESIGN SYNTHESIS AND SAR OF THIOL-CONTANING ARYL SUFONES
78, d3ckiA_, 0.8612, 2.25, 0.259, 221, 193, CRYSTAL STRUCTURE OF THE TACE-N-TIMP-3 COMPLEX
79, p2rjpB1, 0.8612, 2.28, 0.254, 221, 193, CRYSTAL STRUCTURE OF ADAMTS4 WITH INHIBITOR BOUND
80, d1zxcA_, 0.8611, 2.39, 0.212, 255, 198, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) WITH INHIBITOR
81, d3ljtA1, 0.8608, 2.51, 0.211, 262, 199, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
82, d3o64A_, 0.8607, 2.51, 0.211, 262, 199, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH 2-(2-AMINOTHIAZOL- 4-YL)PYRROLIDINE-BASED TARTRATE DIAMIDES
83, d3leaA_, 0.8604, 2.29, 0.254, 222, 193, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH ISOINDOLINONE- BIPHENYL-HYDANTOIN INHIBITOR
84, d2a8hB_, 0.8600, 2.29, 0.254, 222, 193, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THIOMORPHOLINE SULFONAMIDE HYDROXAMATE INHIBITOR
85, p3q2hA1, 0.8597, 2.60, 0.206, 258, 199, ADAMTS1 IN COMPLEX WITH N-HYDROXYFORMAMIDE INHIBITORS OF ADAM-TS4
86, d1bkcA_, 0.8597, 2.50, 0.211, 260, 199, CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)
87, d3g42D_, 0.8595, 2.33, 0.254, 221, 193, CRYSTAL STRUCTURE OF TACE WITH TRYPTOPHAN SULFONAMIDE DERIVATIVE INHIBITOR
88, d3ewjA_, 0.8595, 2.54, 0.211, 259, 199, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH CARBOXYLATE INHIBITOR
89, p3q2gA1, 0.8594, 2.47, 0.208, 256, 197, ADAMTS1 IN COMPLEX WITH A NOVEL N-HYDROXYFORMAMIDE INHIBITORS
90, p2jihA1, 0.8594, 2.38, 0.260, 219, 192, CRYSTAL STRUCTURE OF HUMAN ADAMTS-1 CATALYTIC DOMAIN AND CYSTEINE-RICH DOMAIN (COMPLEX-FORM)
91, d3le9B_, 0.8591, 2.31, 0.208, 259, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH INDAZOLINONE- PHENYL-HYDANTOIN INHIBITOR
92, d2a8hA_, 0.8591, 2.06, 0.262, 217, 191, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THIOMORPHOLINE SULFONAMIDE HYDROXAMATE INHIBITOR
93, d3le9A_, 0.8590, 2.39, 0.213, 252, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH INDAZOLINONE- PHENYL-HYDANTOIN INHIBITOR
94, d3l0tB_, 0.8588, 2.33, 0.204, 258, 196, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDANTOIN INHIBITOR
95, p2jihB1, 0.8588, 2.33, 0.213, 257, 197, CRYSTAL STRUCTURE OF HUMAN ADAMTS-1 CATALYTIC DOMAIN AND CYSTEINE-RICH DOMAIN (COMPLEX-FORM)
96, d3l0vB_, 0.8587, 2.00, 0.280, 216, 189, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THE FIRST HYDANTOIN INHIBITOR OCCUPYING THE S1  POCKET
97, d3kmeA_, 0.8587, 2.33, 0.209, 255, 196, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH PHENYL- PYRROLIDINYL-TARTRATE INHIBITOR
98, d3g42C_, 0.8587, 2.35, 0.204, 254, 196, CRYSTAL STRUCTURE OF TACE WITH TRYPTOPHAN SULFONAMIDE DERIVATIVE INHIBITOR
99, d3kmcB_, 0.8585, 2.48, 0.208, 254, 197, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH TARTRATE-BASED INHIBITOR
100, d1bkcI_, 0.8583, 1.91, 0.282, 215, 188, CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)
101, d3lgpA_, 0.8582, 2.03, 0.280, 216, 189, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH BENZIMIDAZOLYL- THIENYL-TARTRATE BASED INHIBITOR
102, d2i47A_, 0.8582, 2.30, 0.204, 252, 196, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH INHIBITOR
103, d3l0tA_, 0.8581, 2.33, 0.208, 259, 197, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDANTOIN INHIBITOR
104, d2fv9A_, 0.8580, 2.50, 0.208, 251, 197, CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH JMV 390-1
105, d1bkcE_, 0.8580, 2.31, 0.204, 254, 196, CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)
106, d3kmeB_, 0.8577, 2.10, 0.279, 217, 190, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH PHENYL- PYRROLIDINYL-TARTRATE INHIBITOR
107, d3kmcA_, 0.8576, 2.32, 0.204, 252, 196, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH TARTRATE-BASED INHIBITOR
108, d3edzA_, 0.8575, 2.50, 0.208, 253, 197, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR
109, d3leaB_, 0.8572, 2.44, 0.208, 256, 197, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH ISOINDOLINONE- BIPHENYL-HYDANTOIN INHIBITOR
110, d3e8rB_, 0.8572, 2.31, 0.209, 254, 196, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR
111, d2i47B_, 0.8572, 2.25, 0.205, 254, 195, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH INHIBITOR
112, p3q2gB1, 0.8571, 2.50, 0.208, 251, 197, ADAMTS1 IN COMPLEX WITH A NOVEL N-HYDROXYFORMAMIDE INHIBITORS
113, d3lgpB_, 0.8570, 2.41, 0.208, 255, 197, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH BENZIMIDAZOLYL- THIENYL-TARTRATE BASED INHIBITOR
114, p2rjpA1, 0.8570, 2.59, 0.207, 254, 198, CRYSTAL STRUCTURE OF ADAMTS4 WITH INHIBITOR BOUND
115, d2fv5B_, 0.8570, 2.53, 0.208, 254, 197, CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH IK682
116, d3ewjB_, 0.8569, 2.45, 0.208, 256, 197, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH CARBOXYLATE INHIBITOR
117, d3g42B_, 0.8568, 2.35, 0.204, 254, 196, CRYSTAL STRUCTURE OF TACE WITH TRYPTOPHAN SULFONAMIDE DERIVATIVE INHIBITOR
118, d3edzB_, 0.8568, 2.53, 0.208, 255, 197, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR
119, d2ddfB_, 0.8568, 2.54, 0.208, 258, 197, CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH TAPI-2
120, d2ddfA_, 0.8567, 2.44, 0.203, 261, 197, CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH TAPI-2
121, d2fv9B_, 0.8557, 2.32, 0.204, 254, 196, CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH JMV 390-1
122, p2rjpC1, 0.8556, 2.34, 0.209, 254, 196, CRYSTAL STRUCTURE OF ADAMTS4 WITH INHIBITOR BOUND
123, d2i47D_, 0.8553, 1.92, 0.282, 215, 188, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH INHIBITOR
124, d3o64B_, 0.8552, 2.34, 0.209, 254, 196, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH 2-(2-AMINOTHIAZOL- 4-YL)PYRROLIDINE-BASED TARTRATE DIAMIDES
125, d1bkcC_, 0.8550, 2.39, 0.262, 218, 191, CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)
126, d3g42A_, 0.8547, 2.39, 0.203, 256, 197, CRYSTAL STRUCTURE OF TACE WITH TRYPTOPHAN SULFONAMIDE DERIVATIVE INHIBITOR
127, d2i47C_, 0.8540, 2.40, 0.203, 255, 197, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH INHIBITOR
128, p5y2zC1, 0.8538, 2.37, 0.204, 254, 196, CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP AND HUMAN ADAM22 COMPLEX 
129, d4wkiA_, 0.8525, 2.33, 0.209, 254, 196, CRYSTAL STRUCTURE OF HUMAN ADAMTS-4 IN COMPLEX WITH INHIBITOR 5- CHLORO-N-{[(4S)-4-(1-METHYL-1H-IMIDAZOL-2-YL)-25-DIOXOIMIDAZOLIDIN- 4-YL]METHYL}-1-BENZOFURAN-2-CARBOXAMIDE (COMPOUND 11)
130, p2v4bB1, 0.8524, 2.33, 0.209, 254, 196, CRYSTAL STRUCTURE OF HUMAN ADAMTS-1 CATALYTIC DOMAIN AND CYSTEINE-RICH DOMAIN (APO-FORM)
131, d4wkeA_, 0.8513, 2.43, 0.209, 253, 196, CRYSTAL STRUCTURE OF HUMAN ADAMTS-4 IN COMPLEX WITH INHIBITOR 5- CHLORO-N-{[(4R)-25-DIOXO-4-(13-THIAZOL-2-YL)IMIDAZOLIDIN-4- YL]METHYL}-1-BENZOFURAN-2-CARBOXAMIDE (COMPOUND 10)
132, p3q2hB1, 0.8508, 2.36, 0.204, 254, 196, ADAMTS1 IN COMPLEX WITH N-HYDROXYFORMAMIDE INHIBITORS OF ADAM-TS4
133, p2rjpD1, 0.8492, 2.37, 0.263, 217, 190, CRYSTAL STRUCTURE OF ADAMTS4 WITH INHIBITOR BOUND
134, p5y2zG1, 0.8490, 2.51, 0.203, 255, 197, CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP AND HUMAN ADAM22 COMPLEX 
135, d3e8rA_, 0.8490, 2.26, 0.205, 253, 195, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR
136, p6be6C1, 0.8488, 2.29, 0.210, 254, 195, ADAM10 EXTRACELLULAR DOMAIN
137, p5y2zE1, 0.8487, 2.38, 0.209, 254, 196, CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP AND HUMAN ADAM22 COMPLEX 
138, p2v4bA1, 0.8478, 2.39, 0.209, 254, 196, CRYSTAL STRUCTURE OF HUMAN ADAMTS-1 CATALYTIC DOMAIN AND CYSTEINE-RICH DOMAIN (APO-FORM)
139, p6be6A1, 0.8468, 1.79, 0.258, 195, 186, ADAM10 EXTRACELLULAR DOMAIN
140, d4wk7A_, 0.8449, 2.03, 0.273, 214, 187, CRYSTAL STRUCTURE OF HUMAN ADAMTS-4 IN COMPLEX WITH INHIBITOR (COMPOUND 1 2-(4-CHLOROPHENOXY)-N-{[(4R)-4-METHYL-25- DIOXOIMIDAZOLIDIN-4-YL]METHYL} ACETAMIDE)
141, p3b2zB1, 0.8448, 1.91, 0.273, 214, 187, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
142, p3b2zD1, 0.8438, 2.07, 0.273, 214, 187, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
143, p6bdzA1, 0.8386, 2.05, 0.282, 214, 188, ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB
144, p3b2zH1, 0.8331, 1.95, 0.269, 211, 186, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
145, p3b2zE1, 0.8283, 1.79, 0.259, 194, 185, CRYSTAL STRUCTURE OF ADAMTS4 (APO FORM)
146, p3lunA_, 0.7202, 2.67, 0.203, 251, 197, STRUCTURE OF ULILYSIN MUTANT M290C
147, p3lunB_, 0.7189, 2.31, 0.207, 271, 193, STRUCTURE OF ULILYSIN MUTANT M290C
148, p6be6D1, 0.7035, 2.31, 0.207, 271, 193, ADAM10 EXTRACELLULAR DOMAIN
149, p6be6B1, 0.7030, 1.80, 0.259, 194, 185, ADAM10 EXTRACELLULAR DOMAIN
150, p4on1B2, 0.6995, 1.89, 0.276, 212, 185, CRYSTAL STRUCTURE OF METALLOPROTEINASE-II FROM BACTEROIDES FRAGILIS
151, p4on1A2, 0.6975, 2.27, 0.208, 267, 192, CRYSTAL STRUCTURE OF METALLOPROTEINASE-II FROM BACTEROIDES FRAGILIS
152, p3p24B2, 0.6923, 2.03, 0.276, 209, 185, STRUCTURE OF PROFRAGILYSIN-3 FROM BACTEROIDES FRAGILIS
153, p3p24D2, 0.6922, 2.07, 0.263, 216, 186, STRUCTURE OF PROFRAGILYSIN-3 FROM BACTEROIDES FRAGILIS
154, p3p24C2, 0.6911, 2.08, 0.263, 216, 186, STRUCTURE OF PROFRAGILYSIN-3 FROM BACTEROIDES FRAGILIS
155, p3p24A2, 0.6906, 2.24, 0.211, 237, 190, STRUCTURE OF PROFRAGILYSIN-3 FROM BACTEROIDES FRAGILIS
156, p2x7mA_, 0.6377, 1.94, 0.268, 208, 183, CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM METHANOPYRUS KANDLERI AT 1.5 A RESOLUTION
157, p3lmcA_, 0.6150, 1.91, 0.271, 208, 181, CRYSTAL STRUCTURE OF ZINC-DEPENDENT PEPTIDASE FROM METHANOCORPUSCULUM LABREANUM (STRAIN Z) NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MUR16
158, p4axqA_, 0.5904, 3.32, 0.128, 259, 179, CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 1.4 A RESOLUTION
159, p3zvsB_, 0.5824, 3.32, 0.128, 259, 179, CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 1.4 A RESOLUTION COMPLEXED WITH MALONATE
160, p4a3wA_, 0.5796, 3.33, 0.128, 259, 179, CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 2.16 A RESOLUTION COMPLEXED WITH CITRATE
161, p2j83A1, 0.5791, 2.09, 0.190, 193, 158, ULILYSIN METALLOPROTEASE IN COMPLEX WITH BATIMASTAT.
162, p2j83B1, 0.5780, 2.08, 0.190, 195, 158, ULILYSIN METALLOPROTEASE IN COMPLEX WITH BATIMASTAT.
163, p3zvsA_, 0.5775, 2.71, 0.154, 200, 169, CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 1.4 A RESOLUTION COMPLEXED WITH MALONATE
164, p3lumD1, 0.5772, 2.68, 0.155, 200, 168, STRUCTURE OF ULILYSIN MUTANT M290L
165, p3lumA1, 0.5770, 2.68, 0.155, 200, 168, STRUCTURE OF ULILYSIN MUTANT M290L
166, p3lumC1, 0.5762, 2.78, 0.145, 207, 166, STRUCTURE OF ULILYSIN MUTANT M290L
167, p3lumB1, 0.5760, 2.79, 0.145, 209, 166, STRUCTURE OF ULILYSIN MUTANT M290L
168, p2ckiA1, 0.5742, 2.79, 0.145, 209, 166, STRUCTURE OF ULILYSIN A MEMBER OF THE PAPPALYSIN FAMILY OF METZINCIN METALLOENDOPEPTIDASES.
169, p3zvsC_, 0.5736, 2.79, 0.145, 200, 166, CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM ARCHAEOGLOBUS FULGIDUS AT 1.4 A RESOLUTION COMPLEXED WITH MALONATE
170, p2ckiB1, 0.5730, 2.81, 0.145, 203, 166, STRUCTURE OF ULILYSIN A MEMBER OF THE PAPPALYSIN FAMILY OF METZINCIN METALLOENDOPEPTIDASES.
171, d1lmlA_, 0.5656, 3.00, 0.171, 180, 158, LEISHMANOLYSIN
172, d4xctA_, 0.5611, 3.00, 0.171, 180, 158, CRYSTAL STRUCTURE OF A HYDROXAMATE BASED INHIBITOR ARP101 (EN73) IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN.
173, p2xs3B_, 0.5610, 2.46, 0.186, 186, 145, STRUCTURE OF KARILYSIN CATALYTIC MMP DOMAIN
174, d1os2C1, 0.5610, 2.46, 0.186, 186, 145, TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12
175, d1os2F1, 0.5609, 3.15, 0.156, 163, 147, TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12
176, p2xs4A_, 0.5603, 3.15, 0.156, 163, 147, STRUCTURE OF KARILYSIN CATALYTIC MMP DOMAIN IN COMPLEX WITH MAGNESIUM
177, p6esmA_, 0.5599, 3.08, 0.167, 160, 144, CRYSTAL STRUCTURE OF MMP9 IN COMPLEX WITH INHIBITOR BE4. 
178, d1os9D1, 0.5599, 2.48, 0.182, 158, 137, BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12
179, d1os9C1, 0.5598, 3.22, 0.148, 183, 142, BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12
180, d5i12A_, 0.5597, 3.26, 0.155, 183, 142, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-9 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED ARYLSULFONAMIDE CARBOXYLATE WATER-SOLUBLE INHIBITOR (DC27).
181, p4jqgB_, 0.5596, 3.02, 0.169, 158, 142, CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE WITH A FLUORINE ATOM.
182, d1buvM_, 0.5595, 3.16, 0.149, 183, 141, CRYSTAL STRUCTURE OF THE MT1-MMP-TIMP-2 COMPLEX
183, d1bqqM_, 0.5595, 3.10, 0.149, 183, 141, CRYSTAL STRUCTURE OF THE MT1-MMP--TIMP-2 COMPLEX
184, d2w0dB1, 0.5594, 3.11, 0.149, 183, 141, DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES.
185, d1uttA_, 0.5594, 3.12, 0.149, 183, 141, CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2- (13-DIOXO-13-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4- (4-ETHOXY[11-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID
186, d4h49C_, 0.5590, 3.27, 0.156, 182, 141, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
187, d2w0dC1, 0.5590, 2.96, 0.177, 158, 141, DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES.
188, p4jqgA_, 0.5589, 3.14, 0.150, 182, 140, CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE WITH A FLUORINE ATOM.
189, d4h1qB_, 0.5589, 3.79, 0.118, 465, 153, CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
190, d4h1qA_, 0.5588, 3.79, 0.118, 465, 153, CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
191, d2w0dA1, 0.5587, 3.01, 0.146, 157, 137, DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES.
192, p5ue3B2, 0.5586, 3.09, 0.122, 166, 139, PROMMP-9DESFNII
193, d5i2zD_, 0.5586, 2.83, 0.176, 163, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATING WATER-SOLUBLE INHIBITOR (DC24).
194, d5i0lA_, 0.5586, 2.82, 0.176, 163, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED ARYLSULFONAMIDE CARBOXYLATE WATER-SOLUBLE INHIBITOR (DC27).
195, p4jijB_, 0.5586, 3.14, 0.122, 167, 139, CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE
196, p6enmA_, 0.5584, 2.91, 0.132, 158, 136, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH HYDROXAMATE INHIBITOR LP168. 
197, p4jijA_, 0.5584, 2.80, 0.176, 163, 136, CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE
198, d5l7fB_, 0.5583, 2.80, 0.176, 163, 136, CRYSTAL STRUCTURE OF MMP12 MUTANT K421A IN COMPLEX WITH RXP470.1 CONJUGATED WITH FLUOROPHORE CY55 IN SPACE GROUP P21.
199, p6elaA_, 0.5581, 2.92, 0.140, 157, 136, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH INHIBITOR BE4. 
200, d4h49D1, 0.5581, 2.98, 0.139, 164, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
201, p5ue4B2, 0.5580, 3.53, 0.158, 174, 146, PROMMP-9DESFNII COMPLEXED TO JNJ0966 INHIBITOR
202, d5l7fA_, 0.5580, 3.53, 0.158, 174, 146, CRYSTAL STRUCTURE OF MMP12 MUTANT K421A IN COMPLEX WITH RXP470.1 CONJUGATED WITH FLUOROPHORE CY55 IN SPACE GROUP P21.
203, p2xs3A_, 0.5580, 3.53, 0.158, 174, 146, STRUCTURE OF KARILYSIN CATALYTIC MMP DOMAIN
204, p6elaD_, 0.5578, 2.89, 0.169, 158, 136, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH INHIBITOR BE4. 
205, d5i2zC_, 0.5578, 2.82, 0.176, 159, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATING WATER-SOLUBLE INHIBITOR (DC24).
206, d3lilA1, 0.5578, 2.95, 0.175, 156, 137, HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
207, d4h49B1, 0.5577, 2.99, 0.168, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
208, d1os9F1, 0.5577, 2.98, 0.139, 164, 137, BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12
209, p6elaC_, 0.5576, 3.06, 0.139, 160, 137, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH INHIBITOR BE4. 
210, d5i3mA_, 0.5576, 3.06, 0.139, 160, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED THIOUREA-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC31).
211, d5i43A_, 0.5575, 2.89, 0.169, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATOR WATER-SOLUBLE INHIBITOR (DC32).
212, d5i0lB1, 0.5575, 3.05, 0.146, 174, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED ARYLSULFONAMIDE CARBOXYLATE WATER-SOLUBLE INHIBITOR (DC27).
213, d4efsA1, 0.5575, 3.05, 0.146, 174, 137, HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
214, d3likA1, 0.5575, 2.99, 0.161, 156, 137, HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
215, d5i4oA_, 0.5574, 3.02, 0.175, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC28).
216, d5i43C_, 0.5574, 2.99, 0.139, 164, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATOR WATER-SOLUBLE INHIBITOR (DC32).
217, d5i2zB_, 0.5574, 2.70, 0.178, 152, 135, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATING WATER-SOLUBLE INHIBITOR (DC24).
218, d5i2zA_, 0.5574, 2.98, 0.139, 164, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATING WATER-SOLUBLE INHIBITOR (DC24).
219, d3ljgA1, 0.5574, 2.84, 0.176, 158, 136, HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
220, d1os9A1, 0.5574, 2.91, 0.176, 157, 136, BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12
221, d5l79A1, 0.5573, 2.83, 0.176, 158, 136, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH RXP470.1 CONJUGATED WITH FLUOROPHORE CY55 IN SPACE GROUP P21212.
222, d4r3vA_, 0.5573, 3.05, 0.146, 171, 137, STRUCTURE OF KARILYSIN PROPEPTIDE AND CATALYTIC MMP DOMAIN
223, d4hmaA_, 0.5573, 2.84, 0.176, 158, 136, CRYSTAL STRUCTURE OF AN MMP TWIN CARBOXYLATE BASED INHIBITOR LC20 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
224, d2wo8B_, 0.5573, 3.11, 0.122, 166, 139, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
225, d1rm8A_, 0.5573, 3.01, 0.175, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-16/MT3- MMP: CHARACTERIZATION OF MT-MMP SPECIFIC FEATURES
226, d5cxaA_, 0.5572, 3.01, 0.168, 157, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A CARBOXYLATE INHIBITOR RELATED TO RXP470
227, d3lirA1, 0.5572, 2.90, 0.176, 158, 136, HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
228, d2woaB_, 0.5572, 2.93, 0.176, 158, 136, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
229, d2woaA_, 0.5572, 2.88, 0.176, 163, 136, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
230, d4h82A_, 0.5571, 2.92, 0.176, 158, 136, CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
231, p6elaB_, 0.5570, 3.02, 0.168, 157, 137, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH INHIBITOR BE4. 
232, d5i43D_, 0.5570, 3.03, 0.168, 157, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATOR WATER-SOLUBLE INHIBITOR (DC32).
233, d5czmA_, 0.5570, 3.03, 0.175, 158, 137, CRYSTAL STRUCTURE OF A MUTATED CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH RXP470
234, d4h82B_, 0.5570, 2.90, 0.176, 158, 136, CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
235, d1os9E1, 0.5570, 3.01, 0.175, 158, 137, BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12
236, p6enmB_, 0.5569, 3.03, 0.168, 156, 137, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH HYDROXAMATE INHIBITOR LP168. 
237, d5i3mD_, 0.5569, 3.04, 0.168, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED THIOUREA-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC31).
238, d5i3mC_, 0.5569, 3.02, 0.168, 157, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED THIOUREA-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC31).
239, d5i3mB_, 0.5569, 3.03, 0.168, 157, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED THIOUREA-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC31).
240, d4gr0A1, 0.5569, 2.85, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470B
241, d2wo9D_, 0.5569, 3.03, 0.175, 163, 137, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
242, d2wo8A_, 0.5569, 2.90, 0.176, 158, 136, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
243, d1l6jA2, 0.5569, 3.22, 0.108, 179, 139, CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B).
244, p5th6A2, 0.5568, 3.22, 0.108, 179, 139, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (APO MMP9)
245, d4h82D_, 0.5568, 3.06, 0.139, 160, 137, CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
246, d4h82C_, 0.5568, 2.87, 0.176, 163, 136, CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
247, d3ts4A1, 0.5568, 3.48, 0.140, 169, 143, HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
248, d3shiG_, 0.5568, 2.93, 0.176, 159, 136, CRYSTAL STRUCTURE OF HUMAN MMP1 CATALYTIC DOMAIN AT 2.2 A RESOLUTION
249, d2wo8D_, 0.5568, 2.89, 0.176, 158, 136, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
250, d1os9B1, 0.5568, 2.88, 0.176, 163, 136, BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12
251, d5cuhA1, 0.5567, 2.90, 0.176, 163, 136, CRYSTAL STRUCTURE MMP-9 COMPLEXES WITH A CONSTRAINED HYDROXAMATE BASED INHIBITOR LT4
252, d4wzvB_, 0.5567, 3.00, 0.139, 160, 137, CRYSTAL STRUCTURE OF A HYDROXAMATE BASED INHIBITOR EN140 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
253, d4r3vB_, 0.5567, 3.03, 0.175, 158, 137, STRUCTURE OF KARILYSIN PROPEPTIDE AND CATALYTIC MMP DOMAIN
254, d4gr3A1, 0.5567, 2.99, 0.168, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470A
255, d5i43B_, 0.5566, 3.04, 0.175, 159, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE CHELATOR WATER-SOLUBLE INHIBITOR (DC32).
256, d5cuhB1, 0.5566, 2.98, 0.132, 160, 136, CRYSTAL STRUCTURE MMP-9 COMPLEXES WITH A CONSTRAINED HYDROXAMATE BASED INHIBITOR LT4
257, d2woaD_, 0.5566, 2.89, 0.176, 163, 136, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
258, d4h76A1, 0.5565, 2.85, 0.162, 152, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A BROAD SPECTRUM HYDROXAMATE INHIBITOR
259, d4h3xA_, 0.5565, 3.01, 0.161, 157, 137, CRYSTAL STRUCTURE OF AN MMP BROAD SPECTRUM HYDROXAMATE BASED INHIBITOR CC27 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
260, d4h3xA1, 0.5565, 2.99, 0.168, 157, 137, CRYSTAL STRUCTURE OF AN MMP BROAD SPECTRUM HYDROXAMATE BASED INHIBITOR CC27 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
261, d5i4oC_, 0.5563, 3.04, 0.168, 157, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC28).
262, d4hmaB_, 0.5563, 2.94, 0.176, 158, 136, CRYSTAL STRUCTURE OF AN MMP TWIN CARBOXYLATE BASED INHIBITOR LC20 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
263, d1utzA_, 0.5563, 2.89, 0.176, 160, 136, CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO (2R)-3-({[4-[(PYRI DIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID
264, d1gxdB3, 0.5563, 3.03, 0.175, 163, 137, PROMMP-2/TIMP-2 COMPLEX
265, d5n5kA_, 0.5562, 3.07, 0.146, 164, 137, HUMAN CATALYTIC MMP-12 IN COMPLEX WITH 5-(12-DITHIOLAN-3-YL)-N-(3- HYDROXYPROPYL)PENTANAMIDE
266, d5i4oD_, 0.5562, 3.01, 0.147, 173, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC28).
267, d5d3cA_, 0.5562, 2.90, 0.132, 160, 136, CRYSTAL STRUCTURE OF A DOUBLE MUTANT CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH AN HYDROXAMATE ANALOGUE OF RXP470
268, d5n5jA_, 0.5561, 2.98, 0.139, 160, 137, HUMAN MMP12 IN COMPLEX WITH 3-(5-(12-DITHIOLAN-3-YL)PENTANAMIDO) PROPANE-1-SULFONATE
269, d5i4oB_, 0.5561, 3.07, 0.175, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A SELECTIVE SUGAR-CONJUGATED TRIAZOLE-LINKED CARBOXYLATE ZINC-CHELATOR WATER-SOLUBLE INHIBITOR (DC28).
270, d4wzvA_, 0.5561, 2.95, 0.140, 156, 136, CRYSTAL STRUCTURE OF A HYDROXAMATE BASED INHIBITOR EN140 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
271, d4h3xB_, 0.5561, 2.92, 0.176, 160, 136, CRYSTAL STRUCTURE OF AN MMP BROAD SPECTRUM HYDROXAMATE BASED INHIBITOR CC27 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
272, d4h3xB1, 0.5561, 2.94, 0.161, 163, 137, CRYSTAL STRUCTURE OF AN MMP BROAD SPECTRUM HYDROXAMATE BASED INHIBITOR CC27 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
273, d4h49A1, 0.5560, 3.04, 0.146, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
274, d2d1oA_, 0.5560, 3.03, 0.131, 158, 137, STROMELYSIN-1 (MMP-3) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR
275, d4ijoA_, 0.5559, 3.21, 0.108, 179, 139, UNRAVELING HIDDEN ALLOSTERIC REGULATORY SITES IN STRUCTURALLY HOMOLOGUES METALLOPROTEASES
276, d3ma2D_, 0.5559, 3.04, 0.175, 158, 137, COMPLEX MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE (MT1-MMP) WITH TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1)
277, d5d2bA1, 0.5558, 3.03, 0.168, 159, 137, CRYSTAL STRUCTURE OF A MUTATED CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH AN HYDROXAMATE ANALOGUE OF RXP470
278, d4h84B1, 0.5558, 2.94, 0.140, 163, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A SELECTIVE CARBOXYLATE BASED INHIBITOR.
279, d3rtuA_, 0.5558, 2.89, 0.176, 160, 136,  
280, d1utzB_, 0.5558, 2.95, 0.176, 158, 136, CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO (2R)-3-({[4-[(PYRI DIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID
281, d4h2eA1, 0.5557, 3.09, 0.146, 164, 137, CRYSTAL STRUCTURE OF AN MMP TWIN INHIBITOR COMPLEXING TWO MMP-9 CATALYTIC DOMAINS
282, d4gqlA1, 0.5557, 3.09, 0.146, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470.1
283, p5th9C2, 0.5556, 3.04, 0.168, 156, 137, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
284, d5h0uA_, 0.5556, 3.09, 0.139, 160, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MEMBRANE TYPE 1 MATRIX METALLOPROTEINASE
285, d2wo8C_, 0.5556, 3.02, 0.175, 159, 137, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
286, d1cglA_, 0.5556, 3.12, 0.139, 166, 137, STRUCTURE OF THE CATALYTIC DOMAIN OF FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
287, d3uvcB1, 0.5555, 2.93, 0.176, 156, 136, MMP12 IN A COMPLEX WITH THE DIMERIC ADDUCT: 5-(5-PHENYLHYDANTOIN)-5- PHENYLHYDANTOIN
288, d3ma2A_, 0.5555, 3.00, 0.168, 156, 137, COMPLEX MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE (MT1-MMP) WITH TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1)
289, d2wo9B_, 0.5555, 2.91, 0.176, 159, 136, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
290, d1hfsA_, 0.5555, 2.93, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764004
291, p5th9A2, 0.5553, 3.04, 0.168, 156, 137, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
292, p5th6C2, 0.5553, 3.06, 0.146, 158, 137, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (APO MMP9)
293, d5labA1, 0.5553, 3.07, 0.146, 164, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR NNGH
294, d2cltB2, 0.5553, 3.07, 0.146, 163, 137, CRYSTAL STRUCTURE OF THE ACTIVE FORM (FULL-LENGTH) OF HUMAN FIBROBLAST COLLAGENASE.
295, d4guyA_, 0.5552, 2.92, 0.176, 158, 136, HUMAN MMP12 CATALYTIC DOMAIN IN COMPLEX WITH*N*-HYDROXY-2-(2-(4- METHOXYPHENYL)ETHYLSULFONAMIDO)ACETAMIDE
296, d2ovzB_, 0.5552, 2.86, 0.191, 171, 136, MMP-9 ACTIVE SITE MUTANT WITH PHOSPHINATE INHIBITOR
297, d1rmzA1, 0.5552, 3.00, 0.175, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR NNGH AT 1.3 A RESOLUTION
298, d4h30B1, 0.5551, 3.44, 0.147, 171, 143, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
299, p3ayuA_, 0.5551, 2.92, 0.176, 158, 136, CRYSTAL STRUCTURE OF MMP-2 ACTIVE SITE MUTANT IN COMPLEX WITH APP- DRIVED DECAPEPTIDE INHIBITOR
300, d1slmA2, 0.5551, 3.03, 0.175, 158, 137, CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME
301, d1c3iB_, 0.5551, 2.94, 0.176, 158, 136, HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812
302, p5ue4A2, 0.5550, 2.99, 0.175, 159, 137, PROMMP-9DESFNII COMPLEXED TO JNJ0966 INHIBITOR
303, d4g9lB_, 0.5550, 3.08, 0.146, 163, 137, STRUCTURE OF MMP3 COMPLEXED WITH NNGH INHIBITOR.
304, d1ck7A7, 0.5550, 3.05, 0.175, 158, 137, GELATINASE A (FULL-LENGTH)
305, d4ja1B_, 0.5549, 3.01, 0.147, 173, 136, STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR
306, d2woaC_, 0.5549, 3.60, 0.160, 170, 144, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
307, d2ow1B_, 0.5549, 3.04, 0.175, 163, 137, MMP-9 ACTIVE SITE MUTANT WITH TRIFLUOROMETHYL HYDROXAMATE INHIBITOR
308, d1cgfA_, 0.5549, 3.10, 0.139, 168, 137, CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF
309, p6eoxA_, 0.5548, 3.05, 0.168, 158, 137, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH CARBOXYLIC INHIBITOR LP165. 
310, p5th9B2, 0.5548, 3.45, 0.147, 168, 143, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
311, d1y93A_, 0.5548, 2.90, 0.176, 162, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH ACETOHYDROXAMIC ACID AT ATOMIC RESOLUTION
312, d1os2D1, 0.5548, 3.05, 0.190, 160, 137, TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12
313, d1eakD2, 0.5548, 3.02, 0.147, 173, 136, CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT
314, p4auoA1, 0.5547, 3.02, 0.147, 173, 136, CRYSTAL STRUCTURE OF MMP-1(E200A) IN COMPLEX WITH A TRIPLE- HELICAL COLLAGEN PEPTIDE
315, d3n2uA_, 0.5547, 2.93, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(4-METHOXY-N(2-(345-TRIHYDROXY-6- (HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YLOXY)ETHYL)PHENYLSULFONAMIDO) ACETAMIDE
316, d1jk3A_, 0.5547, 3.04, 0.131, 172, 137, CRYSTAL STRUCTURE OF HUMAN MMP-12 (MACROPHAGE ELASTASE) AT TRUE ATOMIC RESOLUTION
317, p6eknA_, 0.5546, 3.02, 0.175, 158, 137, CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH INHIBITOR BE7. 
318, d3tskA1, 0.5546, 3.01, 0.140, 155, 136, HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
319, d3n2vA_, 0.5546, 2.93, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(N-HYDROXYETHYL)BIPHENYL-4- YLSULFONAMIDO)ACETAMIDE
320, d3lkaA_, 0.5546, 2.92, 0.176, 158, 136, CATALYTIC DOMAIN OF HUMAN MMP-12 COMPLEXED WITH HYDROXAMIC ACID AND PARAMETHOXY-SULFONYL AMIDE
321, d3lk8A_, 0.5546, 3.03, 0.124, 166, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR PARAMETHOXY-SULFONYL-GLYCINE HYDROXAMATE
322, d2j0tC_, 0.5546, 3.02, 0.197, 170, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-1 IN COMPLEX WITH THE INHIBITORY DOMAIN OF TIMP-1
323, d2hu6A_, 0.5545, 3.04, 0.182, 173, 137, CRYSTAL STRUCTURE OF HUMAN MMP-12 IN COMPLEX WITH ACETOHYDROXAMIC ACID AND A BICYCLIC INHIBITOR
324, d1rosB_, 0.5545, 3.01, 0.147, 173, 136, CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(13-DIOXO-13- DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[11-BIPHENYL]-4- YL)-4-OXOBUTANOIC ACID
325, p5th6D2, 0.5544, 3.03, 0.182, 167, 137, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (APO MMP9)
326, d4ja1A_, 0.5544, 3.00, 0.140, 165, 136, STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR
327, d2w0dD1, 0.5544, 3.04, 0.182, 167, 137, DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES.
328, d2ovzA_, 0.5544, 3.05, 0.175, 163, 137, MMP-9 ACTIVE SITE MUTANT WITH PHOSPHINATE INHIBITOR
329, d1eakB2, 0.5544, 3.01, 0.140, 155, 136, CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT
330, d1eakA2, 0.5544, 3.07, 0.139, 162, 137, CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT
331, d1d8fB_, 0.5544, 3.07, 0.175, 158, 137, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR.
332, d1biwB_, 0.5544, 3.02, 0.147, 173, 136, DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS
333, p4auoB1, 0.5543, 2.89, 0.176, 158, 136, CRYSTAL STRUCTURE OF MMP-1(E200A) IN COMPLEX WITH A TRIPLE- HELICAL COLLAGEN PEPTIDE
334, d3rttA_, 0.5543, 3.14, 0.175, 163, 137, HUMAN MMP-12 CATALYTIC DOMAIN IN COMPLEX WITH*(R)-N*-HYDROXY-1- (PHENETHYLSULFONYL)PYRROLIDINE-2-CARBOXAMIDE
335, d2ow0B_, 0.5543, 2.96, 0.140, 166, 136, MMP-9 ACTIVE SITE MUTANT WITH IODINE-LABELED CARBOXYLATE INHIBITOR
336, d2ovxB_, 0.5543, 3.06, 0.131, 175, 137, MMP-9 ACTIVE SITE MUTANT WITH BARBITURATE INHIBITOR
337, d2j0tA_, 0.5543, 2.95, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-1 IN COMPLEX WITH THE INHIBITORY DOMAIN OF TIMP-1
338, d1su3B3, 0.5543, 2.90, 0.169, 158, 136, X-RAY STRUCTURE OF HUMAN PROMMP-1: NEW INSIGHTS INTO COLLAGENASE ACTION
339, d1oo9A_, 0.5543, 3.06, 0.175, 159, 137, ORIENTATION IN SOLUTION OF MMP-3 CATALYTIC DOMAIN AND N- TIMP-1 FROM RESIDUAL DIPOLAR COUPLINGS
340, p5ue3A2, 0.5542, 2.97, 0.176, 158, 136, PROMMP-9DESFNII
341, d3rtsA_, 0.5542, 2.95, 0.176, 158, 136, HUMAN MMP-12 CATALYTIC DOMAIN IN COMPLEX WITH*N*-HYDROXY-2-(2- PHENYLETHYLSULFONAMIDO)ACETAMIDE
342, d1os2B1, 0.5542, 2.95, 0.176, 158, 136, TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12
343, d1eakC2, 0.5542, 2.94, 0.176, 158, 136, CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT
344, d1d5jB_, 0.5542, 3.08, 0.139, 159, 137, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR.
345, d4h84A1, 0.5541, 2.95, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A SELECTIVE CARBOXYLATE BASED INHIBITOR.
346, d3nx7A_, 0.5541, 3.05, 0.175, 159, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(N-(2-HYDROXYETHYL)4- METHOXYPHENYLSULFONAMIDO)ACETAMIDE
347, d3f17A_, 0.5541, 3.07, 0.147, 169, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-(2-NITROSO-2-OXOETHYL) BIPHENYL-4-SULFONAMIDE
348, d3ehyA_, 0.5541, 3.04, 0.182, 168, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (R)-2-(4- METHOXYPHENYLSULFONAMIDO)PROPANOIC ACID
349, d2srtA_, 0.5541, 3.07, 0.168, 158, 137, CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR
350, d2ow0A_, 0.5541, 2.95, 0.140, 159, 136, MMP-9 ACTIVE SITE MUTANT WITH IODINE-LABELED CARBOXYLATE INHIBITOR
351, d2cltA2, 0.5541, 3.01, 0.140, 166, 136, CRYSTAL STRUCTURE OF THE ACTIVE FORM (FULL-LENGTH) OF HUMAN FIBROBLAST COLLAGENASE.
352, d4i03A_, 0.5540, 2.93, 0.140, 168, 136, HUMAN MMP12 IN COMPLEX WITH A PEG-LINKED BIFUNCTIONAL L-GLUTAMATE MOTIF INHIBITOR
353, d4gr8A_, 0.5540, 3.05, 0.182, 173, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470C
354, d3f1aA_, 0.5540, 3.04, 0.190, 173, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-(2-NITROSO-2-OXOETHYL) BENZENESULFONAMIDE
355, d2ow2A_, 0.5540, 3.13, 0.131, 175, 137, MMP-9 ACTIVE SITE MUTANT WITH DIFLUORO BUTANOIC ACID INHIBITOR
356, d1gxdA3, 0.5540, 2.95, 0.176, 158, 136, PROMMP-2/TIMP-2 COMPLEX
357, d1g4kA_, 0.5540, 2.95, 0.125, 155, 136, X-RAY STRUCTURE OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR COMPLEXED TO STROMELYSIN
358, d1g49B_, 0.5540, 2.95, 0.125, 159, 136, A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
359, d1cgfB_, 0.5540, 3.10, 0.139, 161, 137, CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF
360, p5th6B2, 0.5539, 3.08, 0.139, 164, 137, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (APO MMP9)
361, d4dpeB_, 0.5539, 3.00, 0.190, 168, 137, STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR.
362, d3f15A_, 0.5539, 2.98, 0.147, 173, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (S)-N-(23-DIHYDROXYPROPYL)-4- METHOXY-N-(2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE
363, d1os2E1, 0.5539, 2.95, 0.176, 158, 136, TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12
364, d1os2A1, 0.5539, 3.07, 0.161, 163, 137, TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12
365, d3f19A_, 0.5538, 3.01, 0.140, 165, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR 4-FLUORO-N-(2-NITROSO-2- OXOETHYL)BENZENESULFONAMIDE
366, d3f18A_, 0.5538, 3.04, 0.182, 173, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR 4-FLUORO-N-(2-HYDROXYETHYL)-N- (2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE
367, d2ow1A_, 0.5538, 3.05, 0.175, 158, 137, MMP-9 ACTIVE SITE MUTANT WITH TRIFLUOROMETHYL HYDROXAMATE INHIBITOR
368, d1d7xA_, 0.5538, 2.90, 0.176, 158, 136, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR.
369, d2ovxA_, 0.5537, 2.89, 0.176, 158, 136, MMP-9 ACTIVE SITE MUTANT WITH BARBITURATE INHIBITOR
370, d1slnA_, 0.5537, 2.95, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702842
371, d1d8mB_, 0.5537, 3.07, 0.182, 173, 137, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE- BASED INHIBITOR
372, d2wo9A_, 0.5536, 2.95, 0.140, 159, 136, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
373, d2tclA_, 0.5536, 3.11, 0.131, 172, 137, STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
374, d1rosA_, 0.5536, 3.06, 0.168, 159, 137, CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(13-DIOXO-13- DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[11-BIPHENYL]-4- YL)-4-OXOBUTANOIC ACID
375, d1cgeA_, 0.5536, 2.84, 0.178, 152, 135, CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF
376, d4h2eB1, 0.5535, 2.95, 0.176, 158, 136, CRYSTAL STRUCTURE OF AN MMP TWIN INHIBITOR COMPLEXING TWO MMP-9 CATALYTIC DOMAINS
377, d3shiM_, 0.5535, 2.96, 0.140, 156, 136, CRYSTAL STRUCTURE OF HUMAN MMP1 CATALYTIC DOMAIN AT 2.2 A RESOLUTION
378, d1d7xB_, 0.5535, 2.97, 0.140, 166, 136, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR.
379, d1b3dB_, 0.5535, 3.05, 0.190, 168, 137, STROMELYSIN-1
380, d4ilwF_, 0.5534, 3.04, 0.182, 173, 137, COMPLEX OF MATRIX METALLOPROTEINASE-10 CATALYTIC DOMAIN (MMP-10CD) WITH TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2)
381, d3ljzB1, 0.5534, 3.04, 0.139, 162, 137, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH AN AMINO-2-INDANOL COMPOUND
382, d2d1oB_, 0.5534, 3.06, 0.147, 168, 136, STROMELYSIN-1 (MMP-3) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR
383, d5uwlA_, 0.5533, 3.06, 0.182, 167, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND (S)-17A
384, d4g0dD1, 0.5533, 2.96, 0.176, 158, 136, HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN
385, d3f16A_, 0.5533, 3.06, 0.161, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (R)-N-(3-HYDROXY-1-NITROSO-1- OXOPROPAN-2-YL)-4-METHOXYBENZENESULFONAMIDE
386, d2j0tB_, 0.5533, 3.03, 0.161, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-1 IN COMPLEX WITH THE INHIBITORY DOMAIN OF TIMP-1
387, d1bqoB_, 0.5532, 2.96, 0.176, 158, 136, DISCOVERY OF POTENT ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS
388, d966cA_, 0.5531, 2.96, 0.176, 158, 136, CRYSTAL STRUCTURE OF FIBROBLAST COLLAGENASE-1 COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID
389, d2oxzA_, 0.5530, 2.97, 0.140, 159, 136, HUMAN MMP-12 IN COMPLEX WITH TWO PEPTIDES PQG AND IAG
390, d2ow2B_, 0.5530, 3.04, 0.190, 169, 137, MMP-9 ACTIVE SITE MUTANT WITH DIFLUORO BUTANOIC ACID INHIBITOR
391, d1qiaB_, 0.5529, 3.02, 0.140, 159, 136, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
392, d2oxwA_, 0.5528, 3.05, 0.190, 168, 137, HUMAN MMP-12 COMPLEXED WITH THE PEPTIDE IAG
393, d1qiaC_, 0.5528, 3.04, 0.190, 173, 137, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
394, d1gkcA_, 0.5528, 3.08, 0.175, 162, 137, MMP9-INHIBITOR COMPLEX
395, d4dpeA_, 0.5527, 3.04, 0.139, 163, 137, STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR.
396, d3ehxA_, 0.5527, 3.06, 0.175, 159, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (R)-2-(BIPHENYL-4- YLSULFONAMIDO)-4-METHYLPENTANOIC ACID
397, d3o2xC1, 0.5526, 3.14, 0.139, 162, 137, MMP-13 IN COMPLEX WITH SELECTIVE TETRAZOLE CORE INHIBITOR
398, d3kekA_, 0.5526, 3.07, 0.146, 163, 137, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H- TETRAZOLE COMPOUND
399, d1hfcA_, 0.5526, 3.08, 0.139, 156, 137, 1.56 ANGSTROM STRUCTURE OF MATURE TRUNCATED HUMAN FIBROBLAST COLLAGENASE
400, d4ilwD_, 0.5525, 3.00, 0.175, 173, 137, COMPLEX OF MATRIX METALLOPROTEINASE-10 CATALYTIC DOMAIN (MMP-10CD) WITH TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2)
401, d4h30A1, 0.5525, 3.04, 0.182, 173, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
402, d3uvcA_, 0.5525, 3.04, 0.182, 159, 137, MMP12 IN A COMPLEX WITH THE DIMERIC ADDUCT: 5-(5-PHENYLHYDANTOIN)-5- PHENYLHYDANTOIN
403, d1jizB1, 0.5525, 2.95, 0.162, 163, 136, CRYSTAL STRUCTURE ANALYSIS OF HUMAN MACROPHAGE ELASTASE MMP- 12
404, d1gkcB_, 0.5525, 3.02, 0.190, 168, 137, MMP9-INHIBITOR COMPLEX
405, d1g49A_, 0.5525, 2.97, 0.162, 160, 136, A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
406, d1d8mA_, 0.5525, 3.00, 0.153, 172, 137, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE- BASED INHIBITOR
407, d3shiA_, 0.5524, 2.96, 0.176, 158, 136, CRYSTAL STRUCTURE OF HUMAN MMP1 CATALYTIC DOMAIN AT 2.2 A RESOLUTION
408, d4g0dB1, 0.5522, 3.11, 0.139, 162, 137, HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN
409, d1su3A3, 0.5522, 3.06, 0.190, 173, 137, X-RAY STRUCTURE OF HUMAN PROMMP-1: NEW INSIGHTS INTO COLLAGENASE ACTION
410, d1hy7B_, 0.5522, 3.09, 0.139, 157, 137, A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
411, d1biwA_, 0.5522, 2.97, 0.176, 158, 136, DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS
412, d1kbcA_, 0.5521, 3.03, 0.140, 155, 136, PROCARBOXYPEPTIDASE TERNARY COMPLEX
413, d1fblA2, 0.5521, 3.06, 0.197, 162, 137, STRUCTURE OF FULL-LENGTH PORCINE SYNOVIAL COLLAGENASE (MMP1) REVEALS A C-TERMINAL DOMAIN CONTAINING A CALCIUM-LINKED FOUR-BLADED BETA- PROPELLER
414, d1c8tA_, 0.5521, 2.97, 0.176, 158, 136, HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812
415, d3o2xA1, 0.5520, 3.07, 0.197, 162, 137, MMP-13 IN COMPLEX WITH SELECTIVE TETRAZOLE CORE INHIBITOR
416, d3ljzD1, 0.5520, 3.02, 0.147, 159, 136, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH AN AMINO-2-INDANOL COMPOUND
417, d1qicA_, 0.5519, 3.06, 0.190, 168, 137, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
418, d1cqrB_, 0.5519, 2.97, 0.176, 158, 136, CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION
419, d4fvlB1, 0.5518, 3.02, 0.153, 163, 137, HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN
420, d456cB_, 0.5518, 2.97, 0.162, 164, 136, CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID
421, d2ow9A_, 0.5518, 3.15, 0.139, 157, 137, CRYSTAL STRUCTURE ANALYSIS OF THE MMP13 CATALYTIC DOMAIN IN COMPLEX WITH SPECIFIC INHIBITOR
422, d1qicB_, 0.5518, 3.01, 0.175, 159, 137, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
423, d1jizA1, 0.5518, 3.09, 0.175, 158, 137, CRYSTAL STRUCTURE ANALYSIS OF HUMAN MACROPHAGE ELASTASE MMP- 12
424, d3kecA1, 0.5517, 2.97, 0.169, 158, 136, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A PHENYL-2H-TETRAZOLE COMPOUND
425, d1gkdA_, 0.5517, 3.13, 0.175, 165, 137, MMP9 ACTIVE SITE MUTANT-INHIBITOR COMPLEX
426, d3o2xD1, 0.5516, 3.03, 0.147, 156, 136, MMP-13 IN COMPLEX WITH SELECTIVE TETRAZOLE CORE INHIBITOR
427, d2wo9C_, 0.5516, 2.98, 0.182, 169, 137, MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
428, d1kbcB_, 0.5516, 3.06, 0.190, 169, 137, PROCARBOXYPEPTIDASE TERNARY COMPLEX
429, d1b8yA_, 0.5516, 3.14, 0.139, 156, 137, X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY
430, d3ba0A1, 0.5515, 3.01, 0.153, 172, 137, CRYSTAL STRUCTURE OF FULL-LENGTH HUMAN MMP-12
431, d2oxuA_, 0.5514, 3.09, 0.139, 164, 137, UNINHIBITED FORM OF HUMAN MMP-12
432, d1qicC_, 0.5514, 3.01, 0.182, 171, 137, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
433, d1qiaD_, 0.5514, 3.05, 0.182, 169, 137, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
434, d3tt4A_, 0.5513, 3.11, 0.124, 164, 137, HUMAN MMP8 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
435, d1youB_, 0.5513, 3.13, 0.153, 172, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR
436, d1q3aB_, 0.5513, 3.08, 0.175, 167, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10
437, d1gkdB_, 0.5513, 2.97, 0.162, 163, 136, MMP9 ACTIVE SITE MUTANT-INHIBITOR COMPLEX
438, d3v96B_, 0.5511, 2.98, 0.162, 163, 136, COMPLEX OF MATRIX METALLOPROTEINASE-10 CATALYTIC DOMAIN (MMP-10CD) WITH TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1)
439, d3o2xB1, 0.5511, 3.13, 0.197, 161, 137, MMP-13 IN COMPLEX WITH SELECTIVE TETRAZOLE CORE INHIBITOR
440, d2yigA_, 0.5511, 3.06, 0.197, 173, 137, MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR
441, d2pojA_, 0.5511, 3.02, 0.153, 172, 137, NMR SOLUTION STRUCTURE OF THE INHIBITOR-FREE STATE OF MACROPHAGE METALLOELASTASE (MMP-12)
442, d1zvxA_, 0.5511, 3.05, 0.146, 159, 137, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (R-ENANTIOMER)
443, d3kejA_, 0.5510, 2.99, 0.169, 167, 136, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H- TETRAZOLE COMPOUND
444, d1qicD_, 0.5510, 3.13, 0.197, 161, 137, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
445, d1c8tB_, 0.5510, 3.09, 0.175, 165, 137, HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812
446, d3ljzC1, 0.5509, 2.98, 0.169, 163, 136, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH AN AMINO-2-INDANOL COMPOUND
447, d1g4kC_, 0.5509, 3.04, 0.140, 159, 136, X-RAY STRUCTURE OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR COMPLEXED TO STROMELYSIN
448, d4g9lA_, 0.5508, 2.98, 0.162, 163, 136, STRUCTURE OF MMP3 COMPLEXED WITH NNGH INHIBITOR.
449, d2oy2F_, 0.5507, 3.10, 0.175, 164, 137, HUMAN MMP-8 IN COMPLEX WITH PEPTIDE IAG
450, d1zs0A_, 0.5507, 3.13, 0.117, 164, 137, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (S-ENANTIOMER)
451, d1cizA_, 0.5507, 3.12, 0.197, 167, 137, X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY
452, d1caqA_, 0.5507, 3.00, 0.161, 169, 137, X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY
453, d456cA_, 0.5506, 2.99, 0.176, 158, 136, CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID
454, d4fu4B1, 0.5505, 3.14, 0.197, 161, 137, HUMAN COLLAGENASE 3 (MMP-13) WITH PEPTIDE FROM PRO-DOMAIN
455, d1qibA_, 0.5505, 3.12, 0.197, 162, 137, CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN
456, d1youA_, 0.5504, 3.15, 0.117, 159, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR
457, d1b3dA_, 0.5504, 3.09, 0.153, 165, 137, STROMELYSIN-1
458, d4fvlA1, 0.5503, 3.08, 0.182, 160, 137, HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN
459, d4a7bA_, 0.5503, 3.04, 0.140, 155, 136, MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22
460, d1d8fA_, 0.5503, 3.07, 0.190, 159, 137, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR.
461, d1bqoA_, 0.5503, 3.05, 0.146, 163, 137, DISCOVERY OF POTENT ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS
462, d3dpeA_, 0.5502, 2.99, 0.162, 167, 136, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON- ZINC CHELATING INHIBITOR
463, d1cqrA_, 0.5502, 3.05, 0.161, 164, 137, CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION
464, d1c3iA_, 0.5502, 3.10, 0.124, 163, 137, HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812
465, d4g0dC1, 0.5501, 3.05, 0.176, 163, 136, HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN
466, d3kecB1, 0.5501, 3.14, 0.197, 161, 137, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A PHENYL-2H-TETRAZOLE COMPOUND
467, d2d1nB_, 0.5501, 3.18, 0.181, 167, 138, COLLAGENASE-3 (MMP-13) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR
468, d1z3jA2, 0.5501, 3.11, 0.153, 163, 137, SOLUTION STRUCTURE OF MMP12 IN THE PRESENCE OF N-ISOBUTYL-N- 4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH)
469, d3tvcA_, 0.5500, 3.06, 0.175, 168, 137, HUMAN MMP13 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
470, d2n8rA_, 0.5500, 3.08, 0.197, 168, 137, PRODUCTIVE COMPLEX BETWEEN MMP-12 AND SYNTHETIC TRIPLE-HELICAL COLLAGEN REVEALED THROUGH PARAMAGNETIC NMR
471, d2d1nA_, 0.5500, 3.10, 0.124, 157, 137, COLLAGENASE-3 (MMP-13) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR
472, d1d5jA_, 0.5500, 3.12, 0.124, 163, 137, CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR.
473, d4g0dA1, 0.5499, 3.08, 0.182, 168, 137, HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN
474, d3kryB_, 0.5499, 3.12, 0.197, 168, 137, CRYSTAL STRUCTURE OF MMP-13 IN COMPLEX WITH SC-78080
475, d3dpfA_, 0.5499, 3.10, 0.153, 160, 137, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON- ZINC CHELATING INHIBITOR
476, d1ztqB_, 0.5499, 3.04, 0.153, 172, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033
477, d1ycmA2, 0.5499, 3.03, 0.147, 161, 136, SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 12 (MMP12) IN THE PRESENCE OF N-ISOBUTYL-N-[4- METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH)
478, d1mncA_, 0.5499, 3.10, 0.153, 168, 137, STRUCTURE OF HUMAN NEUTROPHIL COLLAGENASE REVEALS LARGE S1  SPECIFICITY POCKET
479, d1hv5B_, 0.5499, 3.07, 0.197, 169, 137, CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR
480, d3wv1B_, 0.5498, 3.10, 0.153, 172, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH 4- (2-((6-FLUORO-2-((3-METHOXYBENZYL)CARBAMOYL)-4-OXO-34- DIHYDROQUINAZOLIN-5-YL)OXY)ETHYL)BENZOIC ACID
481, d1zp5A_, 0.5498, 3.12, 0.153, 169, 137, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A N- HYDROXYUREA INHIBITOR
482, d1jj9A_, 0.5497, 3.07, 0.197, 169, 137, CRYSTAL STRUCTURE OF MMP8-BARBITURATE COMPLEX REVEALS MECHANISM FOR COLLAGEN SUBSTRATE RECOGNITION
483, d1hv5E_, 0.5497, 3.03, 0.182, 169, 137, CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR
484, d4qkzA_, 0.5496, 3.13, 0.124, 163, 137, X-RAY STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-8 WITH THE INHIBITOR ML115
485, d3dngA_, 0.5495, 3.07, 0.197, 169, 137, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON- ZINC CHELATING INHIBITOR
486, d1japA_, 0.5495, 3.02, 0.182, 170, 137, COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
487, d3kekB_, 0.5494, 3.05, 0.153, 172, 137, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H- TETRAZOLE COMPOUND
488, d1q3aA_, 0.5494, 3.10, 0.153, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10
489, d1qiaA_, 0.5493, 3.10, 0.153, 166, 137, CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
490, d1ztqA_, 0.5491, 3.12, 0.174, 158, 138, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033
491, d3elmB_, 0.5490, 3.11, 0.153, 169, 137, CRYSTAL STRUCTURE OF MMP-13 COMPLEXED WITH INHIBITOR 24F
492, d2yigB_, 0.5490, 3.10, 0.175, 164, 137, MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR
493, d1janA_, 0.5490, 2.99, 0.162, 166, 136, COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (PHE79 FORM)
494, d1a86A_, 0.5489, 3.09, 0.190, 169, 137, MMP8 WITH MALONIC AND ASPARTIC ACID BASED INHIBITOR
495, d4fu4A1, 0.5488, 3.06, 0.146, 172, 137, HUMAN COLLAGENASE 3 (MMP-13) WITH PEPTIDE FROM PRO-DOMAIN
496, d1a85A_, 0.5488, 3.12, 0.161, 164, 137, MMP8 WITH MALONIC AND ASPARAGINE BASED INHIBITOR
497, d3wv2B_, 0.5487, 3.17, 0.117, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N- (3-METHOXYBENZYL)-4-OXO-34-DIHYDROQUINAZOLINE-2-CARBOXAMIDE
498, d2pjtB_, 0.5487, 3.15, 0.153, 160, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344
499, d1jaqA_, 0.5487, 3.06, 0.159, 158, 138, COMPLEX OF 1-HYDROXYLAMINE-2-ISOBUTYLMALONYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
500, d3kryC_, 0.5486, 3.16, 0.117, 158, 137, CRYSTAL STRUCTURE OF MMP-13 IN COMPLEX WITH SC-78080
501, d1i76A_, 0.5486, 3.48, 0.122, 164, 139, COMPLEX OF 2-(BIPHENYL-4-SULFONYL)-1234-TETRAHYDRO- ISOQUINOLINE-3-CARBOXYLIC ACID (D-TIC DERIVATIVE) WITH T CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
502, d4l19B_, 0.5485, 3.11, 0.153, 164, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND Q1
503, d3zxhB_, 0.5485, 3.09, 0.124, 163, 137, MMP-13 COMPLEXED WITH 2-NAPTHYLSULFONAMIDE HYDROXAMIC ACID INHIBITOR
504, d3dngB_, 0.5485, 3.17, 0.117, 158, 137, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON- ZINC CHELATING INHIBITOR
505, d1jh1A_, 0.5485, 3.50, 0.122, 165, 139, CRYSTAL STRUCTURE OF MMP-8 COMPLEXED WITH A 6H-134- THIADIAZINE DERIVED INHIBITOR
506, d5bpaB_, 0.5484, 3.50, 0.122, 165, 139, X-RAY CO-STRUCTURE OF MMP-13 WITH 4-[({5-[2-(ETHOXYCARBONYL)-1H-INDOL- 5-YL]-1-METHYL-1H-PYRAZOL-3-YL}FORMAMIDO)METHYL]BENZOATE
507, d4jpaB_, 0.5484, 3.17, 0.117, 163, 137, MMP13 IN COMPLEX WITH A PIPERAZINE HYDANTOIN LIGAND
508, d3wv1A_, 0.5484, 3.16, 0.117, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH 4- (2-((6-FLUORO-2-((3-METHOXYBENZYL)CARBAMOYL)-4-OXO-34- DIHYDROQUINAZOLIN-5-YL)OXY)ETHYL)BENZOIC ACID
509, d2ozrB_, 0.5484, 3.19, 0.117, 157, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
510, d1mmpA_, 0.5484, 3.16, 0.161, 158, 137, MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR
511, d1jaoA_, 0.5484, 3.11, 0.182, 156, 137, COMPLEX OF 3-MERCAPTO-2-BENZYLPROPANOYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
512, d1i73A_, 0.5484, 3.11, 0.197, 162, 137, COMPLEX OF PRO-LEU-L-TRP PHOSPHONATE WITH THE CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
513, d4l19A_, 0.5483, 3.16, 0.153, 162, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND Q1
514, d3dpfB_, 0.5483, 3.12, 0.153, 166, 137, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON- ZINC CHELATING INHIBITOR
515, d2ozrA_, 0.5483, 3.14, 0.153, 166, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
516, d830cB_, 0.5482, 3.19, 0.117, 164, 137, COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID
517, d5bpaA_, 0.5482, 3.19, 0.117, 158, 137, X-RAY CO-STRUCTURE OF MMP-13 WITH 4-[({5-[2-(ETHOXYCARBONYL)-1H-INDOL- 5-YL]-1-METHYL-1H-PYRAZOL-3-YL}FORMAMIDO)METHYL]BENZOATE
518, d5boyB_, 0.5482, 3.15, 0.153, 172, 137, X-RAY CO-STRUCTURE OF MMP-13 WITH ETHYL 5-(1-METHYL-1H-IMIDAZOL-5-YL)- 1H-INDOLE-2-CARBOXYLATE
519, d3zxhA_, 0.5482, 3.19, 0.117, 158, 137, MMP-13 COMPLEXED WITH 2-NAPTHYLSULFONAMIDE HYDROXAMIC ACID INHIBITOR
520, d3ljzA1, 0.5482, 3.13, 0.153, 161, 137, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH AN AMINO-2-INDANOL COMPOUND
521, d1mmpB_, 0.5482, 3.17, 0.153, 164, 137, MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR
522, d1g05A_, 0.5482, 3.21, 0.117, 158, 137, HETEROCYCLE-BASED MMP INHIBITOR WITH P2 SUBSTITUENTS
523, d1bzsA_, 0.5482, 3.14, 0.153, 164, 137, CRYSTAL STRUCTURE OF MMP8 COMPLEXED WITH HMR2909
524, d5botA_, 0.5481, 3.19, 0.117, 163, 137, X-RAY CO-STRUCTURE OF MMP-13 WITH ETHYL 5-CARBAMOYL-1H-INDOLE-2- CARBOXYLATE
525, d4jp4B_, 0.5481, 3.09, 0.146, 170, 137, MMP13 IN COMPLEX WITH A REVERSE HYDROXAMATE ZN-BINDER
526, d4a7bB_, 0.5481, 3.14, 0.153, 166, 137, MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22
527, d2e2dA_, 0.5481, 3.14, 0.124, 163, 137, FLEXIBILITY AND VARIABILITY OF TIMP BINDING: X-RAY STRUCTURE OF THE COMPLEX BETWEEN COLLAGENASE-3/MMP-13 AND TIMP-2
528, p5uwnD_, 0.5480, 3.20, 0.117, 158, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND 10D
529, d2usnA_, 0.5480, 3.14, 0.153, 166, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803
530, d1g4kB_, 0.5480, 3.14, 0.153, 166, 137, X-RAY STRUCTURE OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR COMPLEXED TO STROMELYSIN
531, d5boyA_, 0.5479, 3.09, 0.146, 170, 137, X-RAY CO-STRUCTURE OF MMP-13 WITH ETHYL 5-(1-METHYL-1H-IMIDAZOL-5-YL)- 1H-INDOLE-2-CARBOXYLATE
532, d3kryA_, 0.5479, 3.14, 0.168, 167, 137, CRYSTAL STRUCTURE OF MMP-13 IN COMPLEX WITH SC-78080
533, d1mmrA_, 0.5479, 3.12, 0.168, 166, 137, MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR
534, d5botB_, 0.5478, 3.20, 0.117, 158, 137, X-RAY CO-STRUCTURE OF MMP-13 WITH ETHYL 5-CARBAMOYL-1H-INDOLE-2- CARBOXYLATE
535, d3wv3B_, 0.5478, 3.20, 0.117, 163, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N- (3-METHOXYBENZYL)-4-OXO-34-DIHYDROTHIENO[23-D]PYRIMIDINE-2- CARBOXAMIDE
536, d2oy4F_, 0.5478, 3.14, 0.153, 166, 137, UNINHIBITED HUMAN MMP-8
537, p5uwnC_, 0.5477, 3.14, 0.102, 163, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND 10D
538, d5b5pB_, 0.5476, 3.14, 0.161, 167, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH 4- OXO-N-(3-(2-(1H-124-TRIAZOL-3-YLSULFANYL)ETHOXY)BENZYL)-34- DIHYDROQUINAZOLINE-2-CARBOXAMIDE
539, d1q3aC_, 0.5476, 3.15, 0.153, 166, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10
540, d1mmbA_, 0.5476, 3.17, 0.153, 169, 137, COMPLEX OF BB94 WITH THE CATALYTIC DOMAIN OF MATRIX METALLOPROTEINASE-8
541, d3kryD_, 0.5474, 3.14, 0.153, 166, 137, CRYSTAL STRUCTURE OF MMP-13 IN COMPLEX WITH SC-78080
542, d2oy2A_, 0.5473, 3.14, 0.147, 166, 136, HUMAN MMP-8 IN COMPLEX WITH PEPTIDE IAG
543, d5b5pA_, 0.5472, 2.97, 0.163, 160, 135, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH 4- OXO-N-(3-(2-(1H-124-TRIAZOL-3-YLSULFANYL)ETHOXY)BENZYL)-34- DIHYDROQUINAZOLINE-2-CARBOXAMIDE
544, d2ow9B_, 0.5472, 3.15, 0.168, 166, 137, CRYSTAL STRUCTURE ANALYSIS OF THE MMP13 CATALYTIC DOMAIN IN COMPLEX WITH SPECIFIC INHIBITOR
545, d1xudB_, 0.5472, 3.01, 0.184, 166, 136, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
546, d5uwkB_, 0.5471, 3.14, 0.124, 165, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND (S)-10A
547, d1xudA_, 0.5471, 3.14, 0.147, 166, 136, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
548, d1xurB_, 0.5470, 3.14, 0.153, 166, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
549, d1xucA_, 0.5470, 3.15, 0.153, 166, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
550, p5uwnE_, 0.5469, 3.09, 0.146, 165, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND 10D
551, d3kejB_, 0.5469, 3.20, 0.153, 165, 137, CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H- TETRAZOLE COMPOUND
552, d1mmqA_, 0.5469, 3.06, 0.190, 165, 137, MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR
553, d5h8xA_, 0.5468, 3.19, 0.190, 168, 137, CRYSTAL STRUCTURE OF THE COMPLEX MMP-8/BF471 (CATECHOL INHIBITOR)
554, d3wv2A_, 0.5468, 3.14, 0.147, 166, 136, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N- (3-METHOXYBENZYL)-4-OXO-34-DIHYDROQUINAZOLINE-2-CARBOXAMIDE
555, d2ozrD_, 0.5468, 3.15, 0.153, 164, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
556, d2ozrC_, 0.5468, 3.13, 0.168, 167, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
557, d1xucB_, 0.5468, 3.15, 0.153, 166, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
558, d5b5oA_, 0.5467, 3.16, 0.153, 166, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N- PHENYL-4-((4H-124-TRIAZOL-3-YLSULFANYL)METHYL)-13-THIAZOL-2-AMINE
559, d1xurA_, 0.5466, 3.14, 0.124, 157, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
560, d3wv3A_, 0.5465, 3.10, 0.153, 166, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N- (3-METHOXYBENZYL)-4-OXO-34-DIHYDROTHIENO[23-D]PYRIMIDINE-2- CARBOXAMIDE
561, d2ozrF_, 0.5462, 3.19, 0.153, 165, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
562, d2jsdA_, 0.5460, 3.16, 0.182, 155, 137, SOLUTION STRUCTURE OF MMP20 COMPLEXED WITH NNGH
563, d5b5oB_, 0.5459, 3.21, 0.117, 158, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N- PHENYL-4-((4H-124-TRIAZOL-3-YLSULFANYL)METHYL)-13-THIAZOL-2-AMINE
564, d1ueaC_, 0.5456, 3.16, 0.153, 162, 137, MMP-3/TIMP-1 COMPLEX
565, d2ozrE_, 0.5454, 3.19, 0.117, 157, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
566, d2ozrH_, 0.5451, 3.19, 0.153, 167, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
567, p5uwnA_, 0.5450, 3.15, 0.161, 166, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND 10D
568, d2ozrG_, 0.5450, 3.20, 0.161, 166, 137, MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-24-DIOXO-6-(3- PHENYLPROP-1-YN-1-YL)-14-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
569, d2oy4A_, 0.5450, 3.21, 0.153, 161, 137, UNINHIBITED HUMAN MMP-8
570, d830cA_, 0.5447, 3.19, 0.161, 169, 137, COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID
571, d1ueaA_, 0.5446, 3.20, 0.161, 166, 137, MMP-3/TIMP-1 COMPLEX
572, d5uwlB_, 0.5445, 3.19, 0.161, 169, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND (S)-17A
573, d2pjtA_, 0.5445, 3.20, 0.153, 167, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344
574, d2jnpA_, 0.5444, 3.12, 0.162, 157, 136, SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-ISOBUTYL-N-[4- METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH)
575, d2pjtD_, 0.5443, 3.15, 0.168, 166, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344
576, d2mlrA_, 0.5441, 3.20, 0.124, 163, 137, MEMBRANE BILAYER COMPLEX WITH MATRIX METALLOPROTEINASE-12 AT ITS ALPHA-FACE
577, d1fm1A_, 0.5441, 3.07, 0.147, 166, 136, SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
578, d5uwmA_, 0.5440, 3.20, 0.168, 166, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND (R)-17A
579, d3i7gA_, 0.5433, 3.16, 0.168, 167, 137, MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR
580, d1cxvB_, 0.5433, 3.21, 0.161, 166, 137, STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13)
581, d3i7iA_, 0.5431, 3.16, 0.147, 167, 136, MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR
582, d3i7gB_, 0.5430, 3.19, 0.161, 169, 137, MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR
583, d1hv5F_, 0.5430, 3.20, 0.153, 168, 137, CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR
584, d1cxvA_, 0.5429, 3.17, 0.153, 167, 137, STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13)
585, p5uwnB_, 0.5427, 3.14, 0.146, 160, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND 10D
586, d4jpaA_, 0.5427, 3.17, 0.153, 165, 137, MMP13 IN COMPLEX WITH A PIPERAZINE HYDANTOIN LIGAND
587, d1usnA_, 0.5425, 3.02, 0.185, 166, 135, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372
588, d1cglB_, 0.5425, 3.15, 0.147, 164, 136, STRUCTURE OF THE CATALYTIC DOMAIN OF FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
589, p4in9A_, 0.5422, 3.15, 0.147, 163, 136, STRUCTURE OF KARILYSIN MMP-LIKE CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORY TETRAPEPTIDE SWFP
590, d3aykA_, 0.5422, 3.25, 0.153, 161, 137, CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A NMR MINIMIZED AVERAGE STRUCTURE
591, d2pjtC_, 0.5421, 3.24, 0.153, 166, 137, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344
592, d5uwkA_, 0.5419, 3.25, 0.117, 157, 137, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND (S)-10A
593, d1hv5D_, 0.5417, 3.13, 0.148, 164, 135, CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR
594, d1flsA_, 0.5416, 3.02, 0.185, 166, 135, SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
595, d2jt5A_, 0.5415, 3.14, 0.140, 162, 136, SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-HYDROXY-2-[N-(2-HYDROXYETHYL)BIPHENYL-4- SULFONAMIDE] HYDROXAMIC ACID (MLC88)
596, d4jp4A_, 0.5412, 3.23, 0.147, 162, 136, MMP13 IN COMPLEX WITH A REVERSE HYDROXAMATE ZN-BINDER
597, d1aykA_, 0.5410, 3.20, 0.197, 161, 137, INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE NMR 30 STRUCTURES
598, d1g05B_, 0.5405, 3.12, 0.156, 161, 135, HETEROCYCLE-BASED MMP INHIBITOR WITH P2 SUBSTITUENTS
599, d2aykA_, 0.5401, 3.32, 0.161, 164, 137, INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE NMR MINIMIZED AVERAGE STRUCTURE
600, d1hv5A_, 0.5399, 3.22, 0.153, 158, 137, CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR
601, d1hv5C_, 0.5398, 3.11, 0.156, 155, 135, CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR
602, d4aykA_, 0.5386, 3.10, 0.148, 165, 135, CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A NMR 30 STRUCTURES
603, d3elmA_, 0.5385, 3.10, 0.148, 160, 135, CRYSTAL STRUCTURE OF MMP-13 COMPLEXED WITH INHIBITOR 24F
604, d1hovA_, 0.5385, 3.11, 0.148, 165, 135, SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020
605, d5uwmB_, 0.5383, 3.17, 0.154, 163, 136, MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND (R)-17A
606, d2jt6A_, 0.5380, 3.55, 0.122, 162, 139, SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF 3-4 -CYANOBYPHENYL-4-YLOXY)-N- HDYDROXYPROPIONAMIDE (MMP-3 INHIBITOR VII)
607, d1hy7A_, 0.5372, 3.14, 0.148, 160, 135, A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
608, d2mlsA_, 0.5363, 3.18, 0.146, 170, 137, MEMBRANE BILAYER COMPLEX WITH MATRIX METALLOPROTEINASE-12 AT ITS BETA- FACE
609, d3i7iB_, 0.5346, 3.14, 0.156, 165, 135, MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR
610, d3ohoA_, 0.5343, 3.09, 0.191, 164, 136, CATALYTIC DOMAIN OF STROMELYSIN-1 IN COMPLEX WITH N-HYDROXY-2-(4- METHYLPHENYLSULFONAMIDO)ACETAMIDE
611, d3ohlA_, 0.5334, 3.07, 0.142, 157, 134, CATALYTIC DOMAIN OF STROMELYSIN-1 IN COMPLEX WITH N-HYDROXY-2-(4- METHOXY-N-(PYRIDINE-3-YLMETHYL)PHENYLSULFONAMIDO)ACETAMIDE
612, d1ztqD_, 0.5328, 3.13, 0.126, 162, 135, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033
613, d2ddyA_, 0.5325, 3.14, 0.146, 157, 137, SOLUTION STRUCTURE OF MATRILYSIN (MMP-7) COMPLEXED TO CONSTRAINT CONFORMATIONAL SULFONAMIDE INHIBITOR
614, d2mzhA2, 0.5318, 3.12, 0.148, 159, 135, NMR SOLUTION STRUCTURE OF THE PRO FORM OF HUMAN MATRILYSIN (PROMMP-7) IN COMPLEX WITH ZWITTERIONIC MEMBRANE
615, d2y6cA1, 0.5280, 3.16, 0.132, 160, 136, THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER
616, d1umtA_, 0.5251, 3.47, 0.123, 162, 138, STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND PH 7.0 32OC 20 MM CACL2 15% ACETONITRILE; NMR AVERAGE OF 20 STRUCTURES MINIMIZED WITH RESTRAINTS
617, d1umsA_, 0.5239, 3.23, 0.161, 158, 137, STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND PH 7.0 32OC 20 MM CACL2 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES
618, d1ztqC_, 0.5223, 3.28, 0.188, 161, 138, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033
619, d3usnA_, 0.5207, 3.16, 0.156, 165, 135, STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859 NMR 1 STRUCTURE
620, p3p1vB2, 0.5204, 3.24, 0.139, 169, 137, CRYSTAL STRUCTURE OF A METALLO-ENDOPEPTIDASES (BACOVA_00663) FROM BACTEROIDES OVATUS AT 1.93 A RESOLUTION
621, d1eubA_, 0.5204, 3.02, 0.180, 166, 133, SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR
622, p3p1vA2, 0.5203, 3.23, 0.139, 157, 137, CRYSTAL STRUCTURE OF A METALLO-ENDOPEPTIDASES (BACOVA_00663) FROM BACTEROIDES OVATUS AT 1.93 A RESOLUTION
623, d2mzeA2, 0.5203, 3.51, 0.123, 162, 138, NMR SOLUTION STRUCTURE OF THE PRO FORM OF HUMAN MATRILYSIN (PROMMP-7)
624, d1bm6A_, 0.5202, 3.60, 0.122, 162, 139, SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDIC INHIBITOR NMR 20 STRUCTURES
625, d2z2dA_, 0.5190, 3.21, 0.146, 169, 137, SOLUTION STRUCTURE OF HUMAN MACROPHAGE ELASTASE (MMP-12) CATALYTIC DOMAIN COMPLEXED WITH A GAMMA-KETO BUTANOIC ACID INHIBITOR
626, d5ue5A2, 0.5160, 3.17, 0.149, 164, 134, PROMMP-7 WITH HEPARIN OCTASACCHARIDE BOUND TO THE CATALYTIC DOMAIN
627, d2y6dA1, 0.5155, 3.41, 0.138, 163, 138, THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER
628, d2k2gA_, 0.5150, 3.14, 0.149, 154, 134, SOLUTION STRUCTURE OF THE WILD-TYPE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 12 (MMP-12) IN COMPLEX WITH A TIGHT-BINDING INHIBITOR
629, p4df9D2, 0.5127, 3.31, 0.188, 161, 138, CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE (BF3526) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.17 A RESOLUTION
630, p4df9C2, 0.5125, 3.04, 0.179, 162, 134, CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE (BF3526) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.17 A RESOLUTION
631, d5ue2A2, 0.5123, 3.20, 0.154, 164, 136, PROMMP-7 WITH HEPARIN OCTASACCHARIDE BRIDGING BETWEEN DOMAINS
632, p4df9A2, 0.5122, 3.11, 0.150, 160, 133, CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE (BF3526) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.17 A RESOLUTION
633, p2krjA_, 0.5121, 3.07, 0.197, 159, 132, HIGH-RESOLUTION SOLID-STATE NMR STRUCTURE OF A 17.6 KDA PROTEIN
634, p4df9E2, 0.5117, 3.05, 0.189, 159, 132, CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE (BF3526) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.17 A RESOLUTION
635, p4df9B2, 0.5117, 3.18, 0.150, 156, 133, CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE (BF3526) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.17 A RESOLUTION
636, p4df9F2, 0.5113, 3.27, 0.146, 173, 137, CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE (BF3526) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.17 A RESOLUTION
637, d2mziA2, 0.5048, 3.31, 0.146, 175, 137, NMR SOLUTION STRUCTURE OF THE PRO FORM OF HUMAN MATRILYSIN (PROMMP-7) IN COMPLEX WITH ANIONIC MEMBRANE
638, d4hx3G1, 0.5047, 3.32, 0.148, 160, 135, CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH S. CAESPITOSUS SNAPALYSIN
639, d4hx3K1, 0.5023, 3.60, 0.174, 166, 138, CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH S. CAESPITOSUS SNAPALYSIN
640, d4hx3E1, 0.5022, 3.69, 0.165, 166, 139, CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH S. CAESPITOSUS SNAPALYSIN
641, d1kuhA_, 0.5022, 3.07, 0.146, 153, 130, ZINC PROTEASE FROM STREPTOMYCES CAESPITOSUS
642, d4hx3I1, 0.5018, 3.44, 0.190, 168, 137, CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH S. CAESPITOSUS SNAPALYSIN
643, d4hx3A1, 0.5018, 3.26, 0.127, 166, 134, CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH S. CAESPITOSUS SNAPALYSIN
644, d1c7kA_, 0.5017, 3.98, 0.120, 171, 142, CRYSTAL STRUCTURE OF THE ZINC PROTEASE
